Exelixis
EXEL
#1726
Rank
โ‚ฌ9.10 B
Marketcap
31,88ย โ‚ฌ
Share price
-1.16%
Change (1 day)
46.81%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company